Repligen | RGEN - Ebitda

Preço das Ações
117.60
Mudança Diária
3.54 3.10%
Mensal
2.87%
Anual
-18.76%
Q2 Previsão
115.08




Ebitda Alterar Data
Agilent USD 540M 74M 2025-09
Align Technology USD 183.84M 19.77M 2025-09
Bio Techne USD 103.42M 7.47M 2025-12
BioMarin Pharmaceutical USD -24.17M 18.91M 2025-12
Bristol-Myers Squibb USD 4.24B 967M 2025-09
Bruker USD 211.6M 207.4M 2025-12
Charles River Laboratories USD 258.06M 24.83M 2025-12
Danaher USD 1.92B 204M 2026-03
Dentsply International USD 135M 32M 2025-12
General Electric Aerospace USD 2.84B 568M 2026-03
Henry Schein USD 291M 4M 2025-12
Illumina USD 332M 12M 2025-09
IQVIA Holdings USD 1.05B 97M 2025-12
Mettler Toledo International USD 322.64M 26.75M 2025-09
Myriad Genetics USD 14.3M 4M 2025-12
OraSure Technologies USD -17.7M 4.06M 2025-12
Pacific Biosciences Of California USD -35.4M 5.78M 2025-09
Pfizer USD 6.08B 351M 2025-09
Repligen USD 39.54M 3.61M 2025-12
Revvity USD 248.91M 48.52M 2025-12
Standard Biotools USD -15.81M 734K 2025-12
Thermo Fisher Scientific USD 2.7B 464M 2026-03
Waters USD 380.97M 85.83M 2025-12
West Pharmaceutical Services USD 226.2M 7.7M 2026-03